Zwierzchowski L, Flechon J, Ollivier-Bousquet M, Houdebine L M
Laboratoire de Physiologie de la Lactation, Institut National de la Recherche Agronomique, Jouy-en-Josas, France.
Biol Cell. 1987;61(1-2):51-7. doi: 10.1111/j.1768-322x.1987.tb00568.x.
Estramustine, a new anti-microtubule drug, was added to the culture medium of rabbit mammary explants with lactogenic hormones. In the absence of the drug, prolactin with insulin and cortisol stimulated DNA synthesis and it induced beta-casein and beta-casein mRNA accumulation in the tissue. As opposed to other anti-microtubule agents such as colchicine, estramustine was unable to prevent prolactin actions. An examination of the mammary cells by immunofluorescence revealed that the microtubule network was significantly altered under the influence of estramustine. These data indicate that the integrity of microtubules is not required for prolactin to deliver its message to the mammary cell. These data also suggest that other anti-microtubule drugs such as colchicine which prevent prolactin action act through their binding to tubulin molecule unrelated to microtubule structures.
雌二醇氮芥是一种新型抗微管药物,被添加到含有催乳激素的兔乳腺外植体培养基中。在无药物的情况下,催乳素与胰岛素和皮质醇共同刺激DNA合成,并诱导组织中β-酪蛋白和β-酪蛋白mRNA积累。与秋水仙碱等其他抗微管药物不同,雌二醇氮芥无法阻止催乳素的作用。通过免疫荧光对乳腺细胞进行检查发现,在雌二醇氮芥的影响下,微管网络发生了显著改变。这些数据表明,催乳素向乳腺细胞传递信息并不需要微管的完整性。这些数据还表明,其他阻止催乳素作用的抗微管药物,如秋水仙碱,是通过与微管蛋白分子结合而起作用的,这种结合与微管结构无关。